Publication | Closed Access

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases

Yttrium-90 Radioembolization TherapyHepatologyMedicineColorectal CancerPathologyIndependent Prognostic FactorLiver CancerOncologyRadiation OncologyKras StatusRadiologyHealth Sciences